Taken together, SREBF1 transcriptional networks likely play a central role in mediating active androgens converted from adrenal androgen precursors to prevent the incidence of NAFLD in young females by both inhibiting de novo fatty acid biosynthesis and meanwhile promoting fatty acid oxidation in liver. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.